General Information of DTT (ID: TTOJ9QL)

DTT Name Endoplasmic reticulum to nucleus signaling 1 (ERN1) DTT Info
Gene Name ERN1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ORIN1001 DM27RXS Metastatic breast cancer 2C6Y Phase 1/2 [1]
------------------------------------------------------------------------------------
11 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
879325-11-8 DMP04Z6 N. A. N. A. Patented [2]
AC1LE05K DMPOR3G N. A. N. A. Patented [3]
BB 0223767 DM2DT6L N. A. N. A. Patented [4]
T8361 DM86BDS N. A. N. A. Patented [4]
US8614253, 29-1 DMJKFVU N. A. N. A. Patented [5]
US8614253, 29-19 DMVI83P N. A. N. A. Patented [6]
US8614253, 32-4 DMRSP2M N. A. N. A. Patented [6]
US8614253, 32-5 DMSQODK N. A. N. A. Patented [4]
US9040714, 155 DMDELNU N. A. N. A. Patented [2]
US9040714, 7 DM53Z4I N. A. N. A. Patented [2]
US9241942, 32-12 DM8GW54 N. A. N. A. Patented [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Patented Agent(s)
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
APY29 DMCOMLS Solid tumour/cancer 2A00-2F9Z Investigative [7]
PMID24749861C34 DMJNQE1 Discovery agent N.A. Investigative [8]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Orinove.
2 IRE-1 inhibitors. US9040714.
3 IRE-1 inhibitors. US9693992.
4 IRE-1 inhibitors. US8614253.
5 IRE-1 inhibitors. US9241942.
6 IRE-1 inhibitors. US9493435.
7 Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a/XBP1s pathway. Food Chem Toxicol. 2018 Apr;114:52-60.
8 Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. J Med Chem. 2014 May 22;57(10):4289-301.